Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Key to changes
?
Text removedfrom 2016 FY- Text added to 2017 FY
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. freshman Bad
|
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. freshman Bad
|
New words:
ADC, adenosine, Alector, amplification, atopic, auditor, bone, cGVHD, concept, consummation, creation, cytarabine, depatuxizumab, DMT, doubtful, EGFR, eleven, endpoint, exploratory, fewer, Fremont, GBM, GmbH, graft, host, IMMhance, intolerant, justify, Kabi, LDAC, lomustine, mafodotin, marrow, MAVIRET, MAVYRET, MURANO, negligence, neurodegenerative, Nutrition, OS, PARP, PCAOB, pibrentasvir, platinum, poly, polymerase, Postretirement, preliminarily, prolonged, pronouncement, proof, recurrent, revealed, Rituxan, Robert, Rubinstein, SLL, SONAR, temozolomide, TMZ, TNBC, topotecan, untaxed, upadacitinib, ustekinumab, vacated, wholly, WM
Removed:
Ablynx, affirmed, allocated, announcement, attaining, basic, Biogen, BMS, break, closing, comprised, concerted, declined, dedicate, distributed, duvelisib, elotuzumab, equitable, Euronext, exclusively, exit, favor, finite, footage, franchise, GlaxoSmithKline, headcount, healthcare, hematologic, Hillman, Hurwich, hypothetical, identifying, improper, inflow, Influenced, jointly, juror, lipid, methodology, Moody, mutually, myeloma, Nanobody, Neurocrine, neurodegeneration, NV, opted, outlook, partnering, Racketeer, rata, RBV, recently, recommended, remanded, repatriate, replaced, returned, reversed, Rochester, seasonal, shared, SICAD, square, Squibb, stable, supporting, suppurativa, terminate, ulcerative, undesignated, usage, withdrew
Valuein 2016 FY filing- Value in 2017 FY filing
Original filings
Filing view